Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover various ways to increase your cash back rewards and enhance your overall savings strategy. Start maximizing your benefits now!
23,199 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A small mortgage broker pulled off a landmark win against a mega lender in a high-stakes deal, offering a playbook fo...
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
As AI memory roars, smart investors look beyond chips to the apps and components that unlock a new supercycle. This a...
New financing dynamics push builder optimism into 2026 even as demand concerns persist. A key survey shows a structur...
Markets edge higher as Tuesday’s best Wall Street analyst calls spotlight Adobe, Meta, and other names across tech, e...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
Investors scanned the markets as AMC faced dilution concerns that weighed on sentiment. This piece breaks down what h...
Trump Media & Technology Group pivots from traditional media toward a Bitcoin treasury, with 2025 revenue of $3.7 mil...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...